Skip to content
Search

Latest Stories

Medicine reclassification: 6 health conditions identified for potential POM to P switch

6 health conditions identified for potential medicine reclassification
Pharmacy medicines provide people with easier access to treatments and encourage self-care (gettyimages)

Applications are invited for reclassification of prescription-only medicines to pharmacy medicines in these therapeutic areas 

The Department of Health and Social Care (DHSC) has published a list of health conditions and categories, where medicines could be reclassified from ‘available only on prescription’ (POM) to ‘available in pharmacy’ (P) or over-the-counter to support patients in self-care and improve access to much-needed medications.

Companies are now being encouraged to apply to the Medicines and Healthcare products Regulatory Agency (MHRA) for reclassification of relevant medicines in these areas.


Six broad health conditions have been identified as suitable for medicine reclassification based on international practice and real-world evidence. These include treatments for allergies, pain management, skin problems, digestive disorders, women's health and oral health.

These conditions were identified following consultation with the Conditions & Category Working Group, comprising government representatives, the NHS, clinicians, pharmacists, and industry experts, in 2024.

The Royal Pharmaceutical Society (RPS) is a member of the working group, which has worked with the MHRA to identify medicines that could be safely reclassified.

After receiving applications, the MHRA will assess each medicine product individually and will only grant reclassification if it is considered safe and appropriate.

Understand medicine reclassification

Reclassification allows medicines to move from prescription-only status to being available in pharmacies or over the counter. This shift enables patients to access necessary treatments more conveniently without having to visit their GP. It also empowers pharmacists to support patients in self-care for common conditions, reducing pressure on primary care services.

RPS President Professor Claire Anderson welcomed the department’s move to reclassify more medicines, noting that it will provide people with “easier access to treatments for a range of symptoms and encourage self-care.”

“Diagnosing and discussing health problems with patients and advising on the benefits and risks of treatment options are integral to the role of the pharmacy team.,” she said.

Professor Anderson emphasised that enabling POM to P switches is crucial in managing primary care demand, as it helps minimise unnecessary GP appointments and A&E attendances for minor conditions and ensures patients receive timely treatment from community pharmacies.

She assured that the RPS will continue working closely with the MHRA and manufacturers to provide guidance, ensuring patient safety.

Bosting self-care could save NHS £1.7 billion annually

Research conducted last year by PAGB, the consumer healthcare association, representing over-the-counter manufacturers, revealed that nearly a quarter of Britons still do not view self-care as their first option for easy-to-treat conditions. The study also highlighted that younger adults tend to lack the confidence in self-care that older generations have.

Michelle Riddalls, CEO of PAGB, stressed the importance of raising awareness about self-care and encouraging patients to seek advice from pharmacies for minor health concerns, helping to alleviate pressure on A&E departments.

Additionally, a study by Frontier Economics, commissioned by PAGB, estimated that greater reliance on self-care and the accessible expertise of high street pharmacies could save the NHS at least £1.7 billion annually in avoidable appointments and prescription costs.

Identified health conditions and medicine categories for reclassification

Conditions

  • Short term sleep aids
  • Oral health
  • Pain management (migraine, osteoarthritis, pain relief /joint pain)
  • Allergic rhinitis
  • Skin (acne, eczema, psoriasis)
  • Conditions that affect women’s health

Indications

Gastro:

  • Heartburn
  • Preventative indigestion
  • Stomach protection

Skin:

  • Acne
  • Actinic Keratoses
  • Eczema
  • Psoriasis

Women’s Health:

  • Heavy periods / Menorrhagia
  • Intimate fungal skin infections
  • UTI (non-antibiotic treatment)

The MHRA has confirmed that it will not consider reclassification applications for medicines containing opioids or antibiotics.

How to Apply

Companies interested in reclassifying a medicine can find detailed guidance on the GOV.UK website underMedicines: Reclassify Your Product. For further inquiries, they can contact the MHRA at variationqueries@mhra.gov.uk.

More For You

Pharmacy owners to receive 19p SAF increase in advance payments for April and May 2025

The Single Activity Fee (SAF) was increased by 19p to £1.46 per item, effective from April 2024.

gettyimages

19p SAF increase to be included in April and May 2025 advance payments

Following discussions with the Department of Health and Social Care (DHSC), Community Pharmacy England (CPE) has agreed a mechanism that will allow pharmacy owners to receive the 19p increase to the Single Activity Fee (SAF) earlier for the dispensing months of April and May 2025.

CPE said: “The advance payments for these dispensing months will be adjusted to incorporate the uplift to the SAF. No adjustment to advance payments will be required from the June 2025 dispensing month onwards.”

Keep ReadingShow less
CPE invites pharmacy owners to share their views on new CPCF funding settlement

What do you think should be the next priority for the Government?

gettyimages

Pharmacy owners asked to share their views on new CPCF arrangements

Community Pharmacy England (CPE) is urging pharmacy owners to share their views on the new Community Pharmacy Contractual Framework (CPCF) funding settlement ahead of its next full Committee meeting, scheduled for 30 April–1 May.

The Committee said it had agreed to the settlement "reluctantly," acknowledging that it represents a significant shift after years of real-terms funding cuts, while admitting that it’s “still not sufficient to match the continued scale of pressures facing pharmacy businesses.”

Keep ReadingShow less
Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less